Company Description

Opal Therapeutics is building the first “Uterus-in-a-dish” platform to replace outdated, irrelevant mouse models with lab-grown uterine organoids that deliver human data from day one, unlocking more accurate drug discovery, better outcomes for women, and major cost savings for pharma.